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Clinical evidence of malignant epithelial tumors developing 
on the lesions of porokeratosis has accumulated. To deter­
mine the cytologic basis for the malignant change of poro­
keratosis, the nuclear DNA content of epidermal cells from 
porokeratosis lesions was measured using microfluorometry. 
A total of 42% of 33 porokeratosis skin lesions in eight of 
the 16 patients showed DNA polyploidization in the epi-
C linical evidence has accumulated of malignant epi­thelial tumors, squamous cell carcinoma, Bowen's disease, and, occasionally, basal-cell carcinoma de­veloping on the lesions of porokeratosis [1,2]. The association has been calculated to occur in 7% of 
porokeratosis patients [3]. Although the pathogenesis of porokera­
tosis remains to be elucidated, a localized clone of abnormal epi­
dermis has been presumed to explain a slight dysplasia of the epi­
dermis sometimes seen in the histology of porokeratosis [4]. 
Furthermore, chromosomal instability in cultured skin fibroblasts 
from patients with porokeratosis was reported, suggesting a relation 
to the induction of malignancy [5]. However, no cytologic abnor­
malities have been established in the epidermis of porokeratosis 
where malignant changes occur. 
Flow cytometry has been used to determine DNA ploidy in var­
ious neoplasias and precancerous conditions in humans. DNA 
ploidy is now known to be a sensitive and reliable marker of such 
conditions [6]. Early premalignant lesions represent a small popula­
tion in a tissue or an organ, however, and it is difficult to detect a 
fraction of early premalignant cells by flow cytometry. On the other 
hand, conventional micro fluorometry is suitable for the detection 
of such a small different cell population. Using this technique, we 
have recently demonstrated abnormal DNA ploidy in the epidermis 
of porokeratosis from several patients [7,8] and postulated that 
porokeratosis is undergoing the neoplastic process. In the present 
report we extended the previous studies to confirm our results and to 
characterize the precancerous nature of porokeratosis using micro­
fluorometric methods. 
MATERIALS AND METHODS 
Materials and Patients All materials were either biopsied or ex­
cised skin specimens from patients with or without porokeratosis 
and healthy individuals without skin diseases. Forty-one specimens 
were taken from 16 patients with porokeratosis (mean age: 53 years, 
range 24- 73), 33 with porokeratosis-affected skin, and the remain­
ing eight with unaffected skin. Included in our study were 11 nor-
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dermis. Most of the porokeratosis skin lesions, with or with­
out DNA polyploidization, increased cell proportions in the 
Sand G2/M phase range. These findings suggest that poro­
keratosis is undergoing the neoplastic process, and is the pre­
cursor skin manifestation of malignant tumors. ] Invest Der­
matoI92:231S-233S, 1989 
mal-appearing skin specimens from four healthy individuals and 
four patients with localized benign skin tumors (mean age: 45 years, 
range 19 - 66); six Bowen's disease specimens from six patients 
(mean age: 63 years, range 42- 73); and three squamous-cell carci­
noma specimens from three patients (mean age: 68 years, range 
64 - 78). One Bowen's disease specimen and another of squamous­
cell carcinoma were from patients with porokeratosis (Patients 1 
and 3 in Table I). 
DNA Measurement Procedural details were described elsewhere 
[7]. Briefly, paraffin-embedded specimens were cut into units 
50 IJ.m thick and deparaffinized. The epidermis or tumor mass was 
trimmed and then loosened by rinsing in Ringer-Lock's solution 
containing 0.05% collagenase for a day at 37°C. The loosened 
specimens were ultrasonified to obtain cell suspensions. The iso­
lated cells were washed and transferred to glass slide. Nuclear DNA 
was then stained by 4',6-diamidino-2-phenyl-indole (DAPI) and 
observed with an Olympus-MMSP-RFS microfluorometer. The 
intensity of the fluorescence produced by the joining of DAPI to the 
thymine-adenine bond of DNA was recorded and analyzed using a 
personal computer combined with a microfluorometer. Stromal 
lymphocytes were used as controls for the normal diploid content. 
One hundred to 300 intact nuclei of epidermal or tumor cells were 
observed and measured to obtain the DNA distribution histograms. 
Polyploid cells were defined as those with a DNA content ex­
ceeding three times normal diploid content. The cell proportion in 
the range of each cell-cycle phase was calculated assuming a normal 
distribution of each peak and defined as increased when it exceeded 
the mean value of the cell population of normal control skins by a 
standard margin of error (j) or two standard margins of error (it) 
(Table I). 
All the specimens were cut thin in a series of thick sections and 
stained with hematoxylin-eosin to verify their histologic character 
and trim for examination. 
RESULTS 
The results of DNA distribution patterns in porokeratosis are briefly 
summarized in Table I. Every porokeratosis specimen showed main 
peak in the normal diploid content area. Polyploid cells were de­
tected frequently in the epidermis of porokeratosis lesions (positive 
in 14 specimens of 33 examined, or 42%; positive in eight cases of 
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Table I. Patients and Summary of DNA Histogram Patterns of 
Porokeratosis' 
Age Polyploid 
P atient Sex' No.b cells' Sd G2M 
73, M 1 4.5 it 
(1 ) 2 2.3 1 
3 1.0 
4 0.5 
5 
2 54, M 1 2.5 it 
2 it 
3 
3 68, M it it 
4 57, F 1 1.5 
2 
5 61, M it 
6 66, M 1 
7 66, F 1 it it 
2 1 it 
3 it it 
4 it 
5 1 
6 1 
8 47, M 
9 51, M it 
10 47, F it 1 
(1 ) 
11 24, F it 
12 54, F 1.1 II 1 
(1 ) 
13 43, M 1 0.9 
(2) 2 it II 
14 63,F 1 1.7 1 it 
(3) 2 2.3 it it 
3 it II 
15 29,F 1 5.4 it 
2 3.9 1 1 
16 47, M 1 19.5 it it 
2 19.0 it 1 
" The numbers in the parenthesis are the number of unaffected-skin specimens exam-
ined. 
b Ordinary number of porokeratosis-Iesional specimens examined of the patient. 
, Percentages of the polypoid cells. 
J The cell population in the cell cycle phase was classified as increased when it 
exceeded the mean value of those from normal control skins by a standard margin of 
error (T) or by two standard margins of error (ii). 
16 examined) ( Table I, Fig lA,B). Polyploid cells varied in number 
among specimens (0.5%-19.5% of total cells measured in a speci­
men), being scattered without any peaks in some cases (Fig lA), or 
with small peaks in other cases (Fig IB) . 
Most of the porokeratosis skin lesions histographically exhibited 
increased proportions of cells in the S and/or Gz/M phase range 
( Table I, Fig IB,C). The mean proportion of cells in the S phase 
range increased from 3.3% (1.0%-5.8%) in 11 control skins to 
7.8% (1.2% -12.2%) in 33 porokeratosis skins and 8.1 % (3.3%-
13.3%) in 19 porokeratosis, the epidermis of which showed no 
polyploid cells. Gz/M phase cells also increased (2.3% in controls to 
5.1 % in 33 and 19 porokeratosis specimens, respectively). 
DNA distribution histograms from eight unaffected skins ob­
tained from patients with porokeratosis showed a diploid pattern 
similar to those of 11 normal-appearing skins from eight control 
donors (Fig ID). DNA polyploidization (1.3%-9.8% polyploid 
cells of total cells measured in a specimen) and an increased propor­
tion of cells in the S (13.6%-24.4%) and Gz/M (5.0%-12.4%) 
phase range of the cell cycle were evident in six specimens from six 
patients with Bowen's disease in a more enhanced fashion than 
those of porokeratosis (Fig IE). The squamous-cell carcinoma spec­
imens showed an apparent aneuploidy, including polyploid cells 
(data not shown). 
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Figure 1. Distribution histogram of DNA content per cell. Horizontal axis: 
DNA content; vertical axis: percentage of nuclei measured. A: Porokeratosis 
(Patient 2, Specimen No. 1). A small amount of polyploid cells is distributed 
without peaks. B: Porokeratosis (Patient 16, Specimen No.1). Polyploid 
cells are present. Small peaks are around 8e. Elevation of S and G,jM 
component is shown. C: Porokeratosis (Patient 7, Specimen No. 3). Eleva­
tion of S and G2/M component is shown. D: Representative DNA histo­
gram from normal-appearing skins from control individuals. Diploid pat­
tern is apparent. E: Representative DNA histogram from Bowen's disease. 
Occurrence of polyploidy and elevated S and G2/M component are evident. 
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The results of our present study demonstrate, in the epidermis of 
porokeratosis, a frequent occurrence of euploid-polyploid DNA 
distribution and increased proportion of cells in the Sand/or G2/M 
phase range of the cell cycle. These findings suggest that porokera­
tosis has neoplastic clones that are responsible for mitotic irregular­
ity and/or hyperproliferative activity. Similar findings, that is, a 
polyploid and/or aneuploid DNA distribution, have already been 
reported in precancerous epithelial conditions like arsenical kera­
tosis, leukoplakia vegetans of the skin [9)' mucosal dysplasia of cervix uteri [10,11)
' 
and colon polyp [12]. Euploid-polyploidization 
and/or euploid proliferation, both of which were demonstrated in 
all cases of Bowen's disease and in many cases of porokeratosis, have 
been known to exist in cervical dysplasia and to precede the aneu­
ploid DNA change that can be seen in carcinoma in situ or full­
blown carcinoma of the cervix uteri [10]. DNA aneuploidy, appar­
ently present in invasive squamous cell carcinoma, was not 
associated with Bowen's disease in our study. However, the poro­
keratosis DNA distribution histographic pattern was, in general, 
intermediate between Bowen's disease and normal control skin. 
Therefore our results are basically in accordance with cytologic 
abnormalities in other precancerous conditions or carcinoma in situ, 
if porokeratosis is presumed to be a precursor of Bowen's disease. 
As described above, euploid proliferation has been demonstrated 
to occur in the early developmental stage of mucosal dysplasia of 
cervix uteri [10]. The higher proportion of cells in the Sand GdM 
phase range in the porokeratosis epidermis is a similar finding and 
may be a reflection of the proliferating potential of a fraction of 
neoplastic clones. Another possibility is the existence of cells with 
aneuploid DNA content between 2C and 4C or around 4C. Re­
cently, slight aneuploidy has been reported to be present in mouse­
skin papilloma, induced by chemical carcinogen applications in a 
shorter period than needed for the induction of carcinoma [12]. This 
report suggests that a slight aneuploidy is an early event in skin 
tumor development. 
The absence of abnormalities described above and a DNA distri­
bution pattern similar to normal control skin (diploid pattern) in the 
epidermis from porokeratosis-unaffected skins of the patient are 
supporting evidence that a porokeratosis skin lesion itself is respon­
sible for the development of malignant skin tumors. This finding is 
compatible with clinical information accumulated thus far [1,2]. 
In recessively inherited chromosomal instability syndromes, such 
as Bloom's syndrome, Fanconi's anemia, and ataxia telangiectasia, 
patients are susceptible to cancer [13 ]. In dominantly inherited dis­
eases with high cancer risk, chromosomal abnormalities seem to 
play an important part in the carcinogenesis [14]. In porokeratosis 
with autosomal dominant inheritance, chromosomal instability has 
been demonstrated in cultured fibroblasts derived from affected le­
sions [5 ]. In view of the association between chromosomal instabil­
ity and malignant disease, such a possible inherent instability is 
probably a causal factor of porokeratosis and malignant tumors. 
In conclusion, our demonstration of abnormal DNA ploidy in the 
epidermis of porokeratosis is evidence that this condition is under-
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going the neoplastic process, and 15 the precursor of malignant 
changes. 
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